Blog

Medetomidine in Fentanyl blog wildwood

Medetomidine in Fentanyl: What to Know About “Rhino Tranq”

Medetomidine is a powerful sedative now being detected in the illegal fentanyl supply. It may cause profound sedation, a very slow heart rate, and low blood pressure. Regular exposure can also lead to a severe withdrawal syndrome that may require emergency or intensive care. Because fentanyl is usually involved, give naloxone during a suspected overdose, call 911, support breathing, and stay with the person even if sedation continues after naloxone. [1][2]

Medetomidine in Fentanyl: What to Know About “Rhino Tranq”

A person can be exposed to medetomidine without ever deciding to take it. The Centers for Disease Control and Prevention reported in April 2026 that the sedative is being found in the U.S. illegal drug supply, primarily mixed with illegally manufactured fentanyl. It has been reported across the country, with the highest concentrations so far in the Northeast. [1][2]

That matters for anyone who uses fentanyl, counterfeit pills, or an unregulated powder sold as another opioid. The substance in the bag may not match the name on the bag, and familiar overdose responses may not fully explain what rescuers see.

What Is Medetomidine?

Medetomidine is an alpha-2 adrenergic agonist used as a veterinary sedative. It is not approved for use in people. A related medication, dexmedetomidine, is used in human medical settings under controlled conditions, but that does not make street medetomidine safe. CDC testing suggests that the medetomidine appearing in illegal drug samples is being produced outside normal pharmaceutical channels. [2]

Medetomidine is sometimes called “rhino tranq,” “mede,” or “dex.” Those names can create confusion with xylazine, another veterinary sedative found in fentanyl. They are not the same substance, and the most urgent concern with medetomidine is the combination of prolonged sedation, cardiovascular effects, and potentially severe withdrawal.

How Medetomidine Changes a Fentanyl Overdose

Fentanyl can stop or dangerously slow breathing. Medetomidine can add profound sedation, bradycardia (a slow heart rate), and hypotension (low blood pressure). In a mixed exposure, a person may be difficult to wake, breathe slowly or irregularly, have pale or blue-gray skin, and remain heavily sedated even after naloxone improves breathing. [2]

What you may see What to do
Person will not wake, breathing is slow or irregular, lips or fingertips look blue or gray Call 911 immediately. Give naloxone. Begin rescue breathing or CPR if trained and follow dispatcher instructions.
Breathing improves after naloxone but the person remains deeply sedated Do not assume the emergency is over. A non-opioid sedative may still be active. Keep monitoring breathing and stay until help arrives.
Very slow pulse, faintness, cold or clammy skin, or collapse Treat it as an emergency. Do not make the person walk, shower, or “sleep it off.”
Person wakes and becomes agitated, nauseated, anxious, or severely hypertensive Tell emergency clinicians about possible fentanyl plus medetomidine exposure. Severe withdrawal may need hospital-level care.

Naloxone Still Matters

Naloxone does not reverse medetomidine, but it can reverse the fentanyl or other opioid that is usually part of the overdose. CDC specifically advises giving an opioid overdose reversal medication when an overdose involving medetomidine is suspected because restoring breathing is the immediate priority. [2]

Continued sedation after naloxone is not evidence that naloxone “failed.” It may mean that the opioid effect improved while the non-opioid sedative remained active. More than one naloxone dose may be needed for a potent opioid exposure. Emergency medical evaluation is still necessary.

OVERDOSE RESPONSE

Give naloxone, call 911, support breathing, place the person on their side if they are breathing but unconscious, and stay. Never leave someone alone because they briefly woke up.

Why Medetomidine Withdrawal Can Be Severe

The emerging withdrawal picture is one of the most important differences between medetomidine and many other adulterants. CDC warns that regular exposure can lead to a syndrome similar to severe clonidine withdrawal. Reported features include very high blood pressure, anxiety, nausea, vomiting, and rapidly changing levels of alertness. Some cases have required emergency or intensive care because uncontrolled blood pressure and agitation can injure organs. [1][2]

Withdrawal can become apparent when someone stops using, cannot obtain the same supply, or receives naloxone during an overdose. This does not mean naloxone should be withheld. It means emergency clinicians need to know that a person may have been exposed to both an opioid and an alpha-2 sedative.

Medetomidine and Xylazine Are Not Interchangeable

Feature Medetomidine Xylazine
Drug class Alpha-2 adrenergic veterinary sedative; not approved for people Alpha-2 adrenergic veterinary sedative; not approved for people
Current public-health concern Profound sedation, slow heart rate, low blood pressure, and severe withdrawal with hypertension Sedation, low blood pressure, slow heart rate, and severe skin wounds reported with repeated exposure
Naloxone response Does not reverse medetomidine, but should be given for likely fentanyl exposure Does not reverse xylazine, but should be given for likely fentanyl exposure
Consumer testing Not reliably identified by standard home fentanyl test strips Not reliably identified by standard home fentanyl test strips

A person cannot reliably identify either drug by color, taste, packaging, or the effect of one dose. Local drug-checking services may provide more information, but availability and test panels vary.

Can Fentanyl Test Strips Detect Medetomidine?

No. Fentanyl test strips are designed to detect fentanyl in a sample; they do not tell you whether medetomidine is present. A positive fentanyl result is still useful, but a negative or positive result cannot establish that the sample is free of other sedatives, nitazenes, or novel compounds.

Risk-reduction steps include carrying naloxone, avoiding use alone, using a very small test amount, avoiding combinations with alcohol or benzodiazepines, and knowing how to call for emergency help. These steps reduce risk; they do not make an unpredictable supply safe.

When Emergency Care Should Come Before Rehab

Someone with severe sedation, abnormal breathing, chest pain, a very slow pulse, fainting, seizures, confusion, hallucinations, or extreme blood pressure changes needs emergency medical care first. Medetomidine withdrawal may be too medically complex for a routine home detox or a non-hospital setting.

After a person is medically stabilized, the next step is a full substance-use assessment. Treatment may need to address opioid dependence, repeated exposure to an adulterated supply, co-occurring anxiety or trauma, overdose risk, and the practical conditions that make return to use more likely.

How Wildwood Recovery Can Support the Next Step

Wildwood Recovery in Thousand Oaks offers physician-supervised detoxification and a continuum that includes residential and outpatient care. The right starting point depends on the person’s current medical stability, substances used, withdrawal history, mental health, home environment, and previous treatment experience. [3][4]

For a suspected medetomidine emergency, call 911 or Poison Help at 1-800-222-1222. For help planning addiction treatment after emergency stabilization, contact Wildwood Recovery for an individualized assessment.

Frequently Asked Questions

Is medetomidine the same as xylazine?

No. Both are veterinary alpha-2 sedatives and both may appear with fentanyl, but they are different drugs. Medetomidine is drawing particular concern because regular exposure can produce severe withdrawal with dangerous blood pressure changes.

Does naloxone work on rhino tranq?

Naloxone does not reverse medetomidine itself. It should still be given because fentanyl is involved in most reported medetomidine-related overdoses. Naloxone may restore breathing even if the person remains sedated.

What are the signs of medetomidine withdrawal?

CDC has reported hypertension, anxiety, nausea, vomiting, and fluctuating alertness. Severe symptoms can require emergency or intensive care. Anyone with confusion, chest pain, seizure, extreme agitation, or major blood pressure changes needs urgent evaluation.

Can I tell whether fentanyl contains medetomidine?

Not by appearance, taste, smell, or effect. Standard fentanyl test strips do not test for medetomidine. Specialized drug-checking programs may be able to identify more compounds, depending on local capacity.

Is it safe to detox from medetomidine at home?

Home detox may be dangerous after regular exposure because withdrawal can involve severe hypertension and rapidly changing alertness. A medical assessment is the safest way to determine the appropriate setting.

Why would someone still be unconscious after naloxone?

Naloxone may reverse the opioid component while medetomidine or another sedative remains active. Continued unresponsiveness is an emergency. Support breathing, call 911, and keep monitoring the person.

References

[1] Centers for Disease Control and Prevention. (2026, April 2). Medetomidine situation summary. https://www.cdc.gov/overdose-prevention/situation-summary/medetomidine.html

[2] Centers for Disease Control and Prevention. (2026, April 2). Medetomidine in the U.S. illegal fentanyl supply increasing risk for overdose and severe withdrawal syndrome (HAN 00527). https://www.cdc.gov/han/php/notices/han00527.html

Editorial safety note: This article is educational and is not a substitute for emergency care or an individualized medical plan. Call 911 for an unresponsive person, abnormal breathing, seizure, chest pain, or severe confusion.